Found 68 matching trials
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients PHASE2 This study is a two-part trial consisting of Part A (presented in this reco...
Show More Location
Alta Bates Summit Medical Center
Learn More & Join Trial
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants N/A The purpose of this retrospective observational cohort study is to assess p...
Show More Status
Active Not Recruiting
Location
OptumInsight Life Sciences Inc
Learn More & Join Trial
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia N/A This study will evaluate the risk of progressive multifocal leukoencephalop...
Show More Location
Bristol Myers Squibb
Learn More & Join Trial
A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS PHASE2 The investigators propose to design and conduct a phase II clinical trial t...
Show More Location
Antwerp University Hospital
Learn More & Join Trial
A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults PHASE1 This will be an open-label, non-randomized, single oral dose study in healt...
Show More Location
Quotient Clinical
Learn More & Join Trial
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis PHASE2 The purpose of this study is to evaluate the effectiveness and safety of oz...
Show More Location
Local Institution - 0041
Learn More & Join Trial
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis PHASE3 The purpose of the trial is to determine the safety and efficacy of RPC1063...
Show More Location
Local Institution - 115
Learn More & Join Trial
A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects PHASE1 This is a Phase 1, open-label, single-dose study. Approximately 24 Chinese ...
Show More Location
Capital Medical University - Beijing Anzhen Hospital
Learn More & Join Trial
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod PHASE1 This is a Phase 1, multicenter, nonrandomized, open-label, parallel-group s...
Show More Location
University of Miami Miller School of Medicine
Learn More & Join Trial
Efficacy and Safety Study of Ozanimod in Ulcerative Colitis PHASE2 The purpose of this study is to determine whether RPC1063 is effective in t...
Show More Location
Anaheim Clinical Trials
Learn More & Join Trial